 Katherine Fantauzzo
Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Platelet-Derived Growth Factor alpha | 7 | 2025 | 44 | 4.840 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 4 | 2025 | 29 | 2.320 |
Why?
| | Signal Transduction | 10 | 2025 | 5079 | 1.760 |
Why?
| | Serine-Arginine Splicing Factors | 2 | 2024 | 22 | 1.610 |
Why?
| | Hair Follicle | 8 | 2013 | 46 | 1.300 |
Why?
| | Cleft Palate | 2 | 2022 | 68 | 1.230 |
Why?
| | Endosomes | 3 | 2025 | 136 | 1.190 |
Why?
| | Mesoderm | 4 | 2022 | 144 | 1.030 |
Why?
| | Hypertrichosis | 5 | 2014 | 8 | 1.010 |
Why?
| | Morphogenesis | 5 | 2017 | 166 | 0.970 |
Why?
| | GATA Transcription Factors | 3 | 2011 | 7 | 0.950 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2025 | 152 | 0.900 |
Why?
| | Transcription Factors | 5 | 2017 | 1719 | 0.820 |
Why?
| | MAP Kinase Signaling System | 1 | 2025 | 320 | 0.800 |
Why?
| | Phosphorylation | 6 | 2025 | 1759 | 0.730 |
Why?
| | Ligands | 2 | 2021 | 664 | 0.730 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2024 | 366 | 0.720 |
Why?
| | Neural Crest | 3 | 2021 | 118 | 0.720 |
Why?
| | Palate | 2 | 2022 | 38 | 0.720 |
Why?
| | Cell Proliferation | 3 | 2025 | 2475 | 0.670 |
Why?
| | Phosphoproteins | 2 | 2022 | 338 | 0.650 |
Why?
| | Alternative Splicing | 2 | 2021 | 229 | 0.640 |
Why?
| | Gene Expression Regulation, Developmental | 6 | 2021 | 860 | 0.640 |
Why?
| | Mammals | 2 | 2022 | 283 | 0.570 |
Why?
| | Craniofacial Abnormalities | 3 | 2025 | 72 | 0.560 |
Why?
| | Founder Effect | 1 | 2017 | 11 | 0.550 |
Why?
| | Protein Multimerization | 3 | 2025 | 192 | 0.550 |
Why?
| | Receptor Protein-Tyrosine Kinases | 2 | 2020 | 234 | 0.540 |
Why?
| | Intercellular Signaling Peptides and Proteins | 4 | 2015 | 382 | 0.490 |
Why?
| | Skull | 1 | 2016 | 139 | 0.480 |
Why?
| | Mice | 17 | 2024 | 17787 | 0.480 |
Why?
| | Developmental Biology | 2 | 2025 | 22 | 0.450 |
Why?
| | DNA-Binding Proteins | 3 | 2012 | 1502 | 0.450 |
Why?
| | Multigene Family | 1 | 2015 | 198 | 0.440 |
Why?
| | Animals | 19 | 2025 | 36940 | 0.410 |
Why?
| | SOX9 Transcription Factor | 1 | 2012 | 24 | 0.390 |
Why?
| | Vibrissae | 2 | 2011 | 10 | 0.390 |
Why?
| | Zinc Fingers | 2 | 2008 | 50 | 0.350 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2014 | 528 | 0.320 |
Why?
| | Protein Transport | 2 | 2024 | 445 | 0.320 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2008 | 36 | 0.290 |
Why?
| | Repressor Proteins | 4 | 2012 | 427 | 0.260 |
Why?
| | Cells, Cultured | 3 | 2022 | 4193 | 0.250 |
Why?
| | Embryo, Mammalian | 3 | 2017 | 232 | 0.240 |
Why?
| | Genetics, Medical | 1 | 2025 | 26 | 0.230 |
Why?
| | Protein Binding | 2 | 2024 | 2224 | 0.230 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2025 | 185 | 0.220 |
Why?
| | Genetic Diseases, X-Linked | 2 | 2014 | 24 | 0.200 |
Why?
| | Mutation | 5 | 2016 | 3958 | 0.200 |
Why?
| | HEK293 Cells | 1 | 2025 | 730 | 0.190 |
Why?
| | Cell Membrane | 1 | 2025 | 738 | 0.180 |
Why?
| | Phenotype | 4 | 2023 | 3196 | 0.180 |
Why?
| | DNA Copy Number Variations | 2 | 2012 | 182 | 0.180 |
Why?
| | Prenatal Care | 1 | 2023 | 294 | 0.170 |
Why?
| | Wnt Proteins | 3 | 2011 | 133 | 0.170 |
Why?
| | Amino Acid Motifs | 1 | 2020 | 225 | 0.160 |
Why?
| | Fluorescent Antibody Technique | 2 | 2011 | 390 | 0.160 |
Why?
| | Fetus | 1 | 2023 | 806 | 0.140 |
Why?
| | Epidermis | 2 | 2009 | 157 | 0.140 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 422 | 0.140 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 69 | 0.130 |
Why?
| | Cell Line, Transformed | 1 | 2017 | 145 | 0.130 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 112 | 0.130 |
Why?
| | Humans | 15 | 2025 | 137585 | 0.130 |
Why?
| | T-Box Domain Proteins | 1 | 2017 | 98 | 0.130 |
Why?
| | Alkaline Phosphatase | 1 | 2017 | 148 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 496 | 0.130 |
Why?
| | Dimerization | 1 | 2016 | 199 | 0.130 |
Why?
| | Computer Simulation | 1 | 2020 | 978 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 842 | 0.120 |
Why?
| | Extracellular Matrix Proteins | 1 | 2016 | 153 | 0.120 |
Why?
| | Cell Lineage | 1 | 2016 | 350 | 0.110 |
Why?
| | Cell Movement | 2 | 2017 | 967 | 0.110 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 56 | 0.110 |
Why?
| | Mice, Knockout | 1 | 2021 | 3015 | 0.110 |
Why?
| | Phosphates | 1 | 2015 | 182 | 0.110 |
Why?
| | Hair | 1 | 2014 | 84 | 0.110 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2014 | 137 | 0.100 |
Why?
| | Homeodomain Proteins | 1 | 2017 | 506 | 0.100 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2012 | 30 | 0.090 |
Why?
| | Cholesterol | 1 | 2014 | 410 | 0.090 |
Why?
| | Osteochondrodysplasias | 1 | 2012 | 18 | 0.090 |
Why?
| | Fibroblast Growth Factors | 1 | 2013 | 172 | 0.090 |
Why?
| | Mice, Transgenic | 1 | 2017 | 2167 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 437 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2017 | 2833 | 0.090 |
Why?
| | Microarray Analysis | 1 | 2011 | 117 | 0.090 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2011 | 138 | 0.090 |
Why?
| | In Situ Hybridization | 1 | 2011 | 316 | 0.090 |
Why?
| | Cell Survival | 1 | 2014 | 1120 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 346 | 0.090 |
Why?
| | DNA Primers | 1 | 2011 | 515 | 0.090 |
Why?
| | Cardiomegaly | 1 | 2012 | 175 | 0.090 |
Why?
| | Molecular Sequence Data | 3 | 2012 | 2900 | 0.080 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 2009 | 15 | 0.080 |
Why?
| | Immunohistochemistry | 2 | 2011 | 1738 | 0.080 |
Why?
| | Chromosome Breakage | 1 | 2008 | 23 | 0.070 |
Why?
| | Sp1 Transcription Factor | 1 | 2008 | 24 | 0.070 |
Why?
| | Epidermal Growth Factor | 1 | 2009 | 177 | 0.070 |
Why?
| | Chromosome Inversion | 1 | 2008 | 18 | 0.070 |
Why?
| | Nails, Malformed | 1 | 2007 | 5 | 0.070 |
Why?
| | Thrombospondins | 1 | 2007 | 9 | 0.070 |
Why?
| | Gene Rearrangement | 1 | 2008 | 150 | 0.070 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2008 | 317 | 0.070 |
Why?
| | Organogenesis | 1 | 2007 | 58 | 0.070 |
Why?
| | Organ Specificity | 1 | 2007 | 305 | 0.070 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 189 | 0.060 |
Why?
| | Ectoderm | 1 | 2007 | 53 | 0.060 |
Why?
| | Pedigree | 3 | 2014 | 514 | 0.060 |
Why?
| | Epithelial Cells | 1 | 2012 | 1096 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2023 | 4295 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1062 | 0.060 |
Why?
| | Binding Sites | 1 | 2008 | 1303 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2009 | 5757 | 0.060 |
Why?
| | Cell Cycle | 1 | 2007 | 601 | 0.060 |
Why?
| | Yolk Sac | 1 | 2004 | 5 | 0.060 |
Why?
| | Skin | 1 | 2009 | 752 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2007 | 620 | 0.050 |
Why?
| | Erythroblasts | 1 | 2004 | 19 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2012 | 1774 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2607 | 0.050 |
Why?
| | Female | 8 | 2023 | 73304 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 52 | 0.050 |
Why?
| | Keratinocytes | 2 | 2014 | 249 | 0.050 |
Why?
| | Interferons | 1 | 2023 | 202 | 0.050 |
Why?
| | Workflow | 1 | 2023 | 165 | 0.050 |
Why?
| | Genetic Testing | 1 | 2023 | 460 | 0.040 |
Why?
| | Sequence Analysis, DNA | 2 | 2013 | 812 | 0.040 |
Why?
| | Male | 3 | 2021 | 67762 | 0.030 |
Why?
| | Base Sequence | 2 | 2012 | 2181 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2014 | 115 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2014 | 183 | 0.030 |
Why?
| | Pregnancy | 2 | 2023 | 6763 | 0.030 |
Why?
| | Mutagenesis, Insertional | 1 | 2013 | 65 | 0.030 |
Why?
| | RNA Splicing | 1 | 2014 | 269 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2013 | 297 | 0.020 |
Why?
| | Ubiquitin-Specific Proteases | 1 | 2012 | 8 | 0.020 |
Why?
| | Heterozygote | 1 | 2013 | 293 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2013 | 523 | 0.020 |
Why?
| | Endopeptidases | 1 | 2012 | 90 | 0.020 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2012 | 70 | 0.020 |
Why?
| | Genome, Human | 1 | 2013 | 425 | 0.020 |
Why?
| | Muscle Proteins | 1 | 2012 | 231 | 0.020 |
Why?
| | Tyrphostins | 1 | 2009 | 18 | 0.020 |
Why?
| | EGF Family of Proteins | 1 | 2009 | 17 | 0.020 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 2009 | 23 | 0.020 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2009 | 27 | 0.020 |
Why?
| | Amphiregulin | 1 | 2009 | 25 | 0.020 |
Why?
| | Zinc Finger Protein GLI1 | 1 | 2009 | 25 | 0.020 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2009 | 16 | 0.020 |
Why?
| | Syndecan-1 | 1 | 2009 | 38 | 0.020 |
Why?
| | Tissue Culture Techniques | 1 | 2009 | 78 | 0.020 |
Why?
| | Oncogene Proteins | 1 | 2009 | 59 | 0.020 |
Why?
| | Cell Differentiation | 2 | 2009 | 1991 | 0.020 |
Why?
| | Hyaluronan Receptors | 1 | 2009 | 102 | 0.020 |
Why?
| | Hedgehog Proteins | 1 | 2009 | 195 | 0.020 |
Why?
| | Quinazolines | 1 | 2009 | 251 | 0.020 |
Why?
| | Dermis | 1 | 2007 | 33 | 0.020 |
Why?
| | RNA Splice Sites | 1 | 2007 | 45 | 0.020 |
Why?
| | Cadherins | 1 | 2009 | 206 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 771 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2007 | 29 | 0.020 |
Why?
| | Glycoproteins | 1 | 2009 | 342 | 0.020 |
Why?
| | Antigens, Differentiation | 1 | 2007 | 83 | 0.020 |
Why?
| | Homozygote | 1 | 2007 | 203 | 0.020 |
Why?
| | beta Catenin | 1 | 2009 | 253 | 0.020 |
Why?
| | Feedback, Physiological | 1 | 2007 | 77 | 0.020 |
Why?
| | Trans-Activators | 1 | 2009 | 398 | 0.020 |
Why?
| | Keratins | 1 | 2007 | 173 | 0.020 |
Why?
| | Nasal Mucosa | 1 | 2007 | 107 | 0.020 |
Why?
| | Introns | 1 | 2007 | 258 | 0.020 |
Why?
| | Exons | 1 | 2007 | 355 | 0.020 |
Why?
| | ErbB Receptors | 1 | 2009 | 614 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 840 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2007 | 466 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2189 | 0.010 |
Why?
| | Cell Communication | 1 | 2007 | 315 | 0.010 |
Why?
| | Globins | 1 | 2004 | 22 | 0.010 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2004 | 18 | 0.010 |
Why?
| | Cell Size | 1 | 2004 | 91 | 0.010 |
Why?
| | Erythropoiesis | 1 | 2004 | 55 | 0.010 |
Why?
| | Cell Count | 1 | 2004 | 324 | 0.010 |
Why?
| | Cell Line | 1 | 2007 | 2847 | 0.010 |
Why?
| | Proteins | 1 | 2007 | 1009 | 0.010 |
Why?
| | Infant | 1 | 2014 | 9465 | 0.010 |
Why?
| | Child, Preschool | 1 | 2014 | 11074 | 0.010 |
Why?
| | Gene Expression | 1 | 2004 | 1502 | 0.010 |
Why?
| | Erythrocytes | 1 | 2004 | 700 | 0.010 |
Why?
| | Adolescent | 1 | 2012 | 21513 | 0.010 |
Why?
|
|
Fantauzzo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|